FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used to assess the risk of developing venous thromboembolic complications in patients with novel coronavirus infection COVID-19. Method involves collecting and evaluating anamnesis data, including patient's age, vein thrombosis and/or pulmonary thromboembolism, diagnosed thrombophilia, staying in the intensive care unit or ward, determining D-dimer, body weight index. Derived points are summed up, and the risk of developing venous thromboembolic complications is assessed.
EFFECT: invention enables to objectively and accurately assess the risks of developing the disease and select the correct anticoagulant therapy approach.
2 cl, 2 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF PREDICTING THE DEVELOPMENT OF PULMONARY EMBOLISM DURING THE PREVENTION OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH A NEW CORONAVIRUS INFECTION | 2023 | 
 | RU2802386C1 | 
| METHOD OF TAKING RISK ASSESSMENT OF DEVELOPMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN WOUNDED AND INJURED PEOPLE | 2016 | 
 | RU2657196C2 | 
| METHOD FOR PREDICTING PULMONARY ARTERIAL EMBOLIZATION IN ONCOLOGY PATIENTS WITH LOWER EXTREMITY PHLEBOTHROMBOSIS | 2016 | 
 | RU2664448C2 | 
| METHOD FOR DIAGNOSING THROMBINEMIA IN PATIENTS WITH COVID-19 INFECTION | 2022 | 
 | RU2794035C1 | 
| METHOD OF CLINICAL ASSESSMENT OF THE PROBABILITY OF NON-MASSIVE PULMONARY ARTERY THROMBOEMBOLIA IN FEMALE PATIENTS TAKING COMBINED ORAL CONTRACEPTIVES | 2015 | 
 | RU2601661C1 | 
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PULMONARY ARTERY THROMBOEMBOLIA IN PATIENTS WITH DEEP VENOUS THROMBOSIS | 2013 | 
 | RU2522398C1 | 
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 | 
 | RU2803002C1 | 
| METHOD OF PREDICTING DEVELOPMENT OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH COVID-19 | 2023 | 
 | RU2812718C1 | 
| METHOD FOR PREDICTION OF RISK OF DEVELOPING THROMBOEMBOLIA OF PULMONARY ARTERY | 2012 | 
 | RU2517597C1 | 
| METHOD FOR ANTICOAGULANT THERAPY AND PREVENTION OF THROMBOTIC COMPLICATIONS IN PATIENTS WITH SEVERE BRAIN DAMAGE IN A CHRONIC CRITICAL CONDITION | 2021 | 
 | RU2762945C1 | 
Authors
Dates
2024-10-02—Published
2024-04-23—Filed